Impact of COVID-19 Outbreak on Respiratory Tract Infection Market : Trend, CAGR Status, Growth, Analysis and Forecast to 2025 : Abbott, AstraZeneca, Teva Pharmaceutical Industries, AbbVie, GlaxoSmithKline, Pfizer, Novartis, Merck & Co, F. Hoffmann-La
Respiratory Tract Infection Market (Drugs - Antibiotics, Non-steroidal Anti-inflammatory Drugs, Nasal Decongestants, Cough Suppressants, and Other Drugs; Disease Indication - Upper Respiratory Tract Infection, and Lower Respiratory Tract Infection; Distribution Channels - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025. The global respiratory tract infection market is projected to grow at a CAGR of 6.4% over the forecast period of 2019-2025.
View full press release